AI-designed universal coronavirus vaccine shows promise in first human trial
By
C&EN editorial staff
Pure flour-power. Hearty enough to carry you through lunch.
Summary
University of Cambridge and DIOSynVax researchers have published results from the first human clinical trial of a universal coronavirus vaccine, designed with the help of artificial intelligence for antigen design. The editorial highlights how British research partnerships are advancing vaccine development through AI-driven approaches, emphasizing that skepticism and success both play important roles in scientific progress.
Key quotes
· 3 pulledRecently, University of Cambridge and DIOSynVax researchers published the results of the first human clinical trial of a universal coronavirus vaccine.
Scientists designed the new vaccine candidate with the help of artificial intelligence to provide
A British research partnership points the way on antigen design
You might also wanna read
Scientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,
newatlas.com·10mo ago
Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens
Stanford Medicine researchers have developed a universal vaccine formula that protects mice against a wide range of respiratory viruses, bac
med.stanford.edu·3mo ago
Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses
Stanford University researchers have developed a nasal spray vaccine that could provide universal protection against all coughs, colds, flus
bbc.com·3mo ago
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
cuimc.columbia.edu·9mo agoUndisclosed Deaths in the Pfizer mRNA Covid-19 Vaccine Trial [pdf]
AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t
The Verge·5d agoAI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t
theverge.com·5d ago